focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 160.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.50%)
Open: 162.00
High: 162.00
Low: 162.00
Prev. Close: 162.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gresham Technologies PLC

12 Apr 2024 11:05

RNS Number : 4593K
Mission Trail Capital Mgmt LLC
12 April 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Mission Trail Capital Management, LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Joshua Braden

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gresham Technologies PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

9 April 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5P Ordinary Share

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

0

0

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5P Ordinary Share

Sale

 

1,870,000

160.3 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

11 April 2024

Contact name:

Joshua Braden

Telephone number*:

+1 (512) 537-8677

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFUSUEELSELL
Date   Source Headline
10th Dec 20135:38 pmRNSHolding(s) in Company
3rd Dec 20137:00 amRNSCTC contract win & placing to raise £3 million
25th Nov 20135:06 pmRNSHolding(s) in Company
18th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20135:37 pmRNSDirector's Dealing
3rd Oct 20137:00 amRNSChange of Registered Office
14th Aug 20137:00 amRNSHalf Yearly Report
26th Jul 20137:00 amRNSCTC Significant Contract Win
25th Jul 20133:43 pmRNSHolding(s) in Company
28th Jun 201310:45 amRNSCTC Significant Contract Win
3rd Jun 20137:00 amRNSCTC Contract Win
15th May 201312:35 pmRNSResult of AGM
15th May 20137:00 amRNSInterim Management Statement
26th Mar 20137:00 amRNSAnnual Financial Report Announcement
11th Mar 20137:00 amRNSDisposal of Subsidiary
5th Feb 20137:00 amRNSTrading update
7th Nov 20127:00 amRNSInterim Management Statement
27th Sep 20122:43 pmRNSHolding(s) in Company
7th Aug 20127:00 amRNSHalf Yearly Report
10th Jul 20127:00 amRNSFurther information on Significant Contract Win
2nd Jul 20129:35 amRNSDirector/PDMR Shareholding
13th Jun 20121:16 pmRNSHolding(s) in Company
13th Jun 20121:03 pmRNSHolding(s) in Company
7th Jun 20122:26 pmRNSHolding(s) in Company
28th May 20129:19 amRNSDirector/PDMR Shareholding
22nd May 20129:14 amRNSDirector/PDMR Shareholding
8th May 20122:48 pmRNSResult of AGM
8th May 20129:23 amRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSInterim Management Statement
24th Apr 201210:05 amRNSDirector/PDMR Shareholding
18th Apr 20127:00 amRNSAnnual Information Update
17th Apr 201212:26 pmRNSGresham Computing Notice of 2012 AGM & AFR 2011
5th Apr 20125:20 pmRNSDirector's Dealings
30th Mar 20125:24 pmRNSDirector/PDMR Shareholding
26th Mar 20127:00 amRNSDirector/PDMR Shareholding
23rd Mar 201210:56 amRNSDirector/PDMR Shareholding
22nd Mar 201212:00 pmRNSHolding(s) in Company
20th Mar 20127:00 amRNSAnnual Financial Report Announcement
12th Mar 20124:10 pmRNSHolding(s) in Company
12th Mar 20122:18 pmRNSHolding(s) in Company
20th Feb 20125:47 pmRNSHolding(s) in Company
26th Jan 20121:54 pmRNSHolding(s) in Company
25th Jan 20121:02 pmRNSHolding(s) in Company
5th Jan 20127:00 amRNSTrading Update
22nd Dec 20119:42 amRNSTrading Update
31st Oct 201111:34 amRNSDirector's Dealings
13th Oct 20117:00 amRNSInterim Management Statement
11th Oct 20112:52 pmRNSHolding(s) in Company
3rd Oct 20117:00 amRNSDirector/PDMR Shareholding
26th Sep 20117:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.